Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)

Autor: McCullough, Peter A. *, Ballantyne, Christie M., Sanganalmath, Santosh K., Langslet, Gisle, Baum, Seth J., Shah, Prediman K., Koren, Andrew, Mandel, Jonas, Davidson, Michael H.
Zdroj: In The American Journal of Cardiology 15 April 2018 121(8):940-948
Databáze: ScienceDirect
Externí odkaz: